The findings in this report relate to the quality assurance (QA) visit of the Lincolnshire breast screening service held on 19 October 2017. The QA visit team identified 5 high priority findings as summarised below: the breast services review should be concluded
Evaluates the quality of care provided to women aged 70 years or older by breast cancer services in England and Wales. The aim of the audit is to evaluate the care delivered to women from the point of initial diagnosis to
The findings in this report relate to the quality assurance visit of the Isle of Wight screening service held on 21 November 2017. The unit consistently exceeds the national achievable standard for uptake of 70%. The overall uptake for the 50-70 age
Research from Breast Cancer Now into the availability of breast reconstruction surgery, that finds some Clinical Commissioning Groups (CCGs) in England are restricting access to this surgery. Since 2012, 22.6% of CCGs have introduced official policies restricting breast reconstruction surgery while a further 4.3% have policies that are either informal
Executive summary of quality assurance (QA) visit to Crewe Breast Screening Service held on 28 September 2017. Finds major staffing shortages across radiology, pathology and some vacancies in surgery and radiography making the service extremely vulnerable. The current team works exceptionally hard to deliver
Quality assurance aims to maintain national standards and promote continuous improvement in breast screening. This is to ensure that all eligible people have access to a consistently high-quality service wherever they live. QA visits are carried out by the Public
Report that finds while outcomes for breast cancer are good and improving, overall progress is disguising variations across the country. Some women are being diagnosed at an earlier stage of their breast cancer than others, greatly improving their chances of survival. Some women
Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery in adults.
Evidence-based recommendations on fulvestrant (Faslodex) for treating locally advanced or metastatic (secondary), oestrogen-receptor positive breast cancer in postmenopausal women who have not had endocrine therapy before.
Executive summary of quality assurance (QA) visit to Gloucestershire Breast Screening Service held on 27 September 2017. The QA visit team identified 8 high priority findings as summarised below: the current staffing for breast care nurses does not meet nursing guidelines for
Executive summary of quality assurance (QA) visit to the East Berkshire breast screening service held on 5 July 2017. Quality assurance (QA) aims to maintain national standards and promote continuous improvement in screening. This is to ensure that all eligible people have access
Executive summary of quality assurance (QA) visit in Warrington, Halton, St Helens and Knowsley held on 14 July 2016. Found that: strategic planning is required particularly in relation to staffing, equipment replacement and accommodation. Current radiographic staffing levels are well below NHSBSP recommended
Report suggesting progress on breast cancer in the UK is “stalling” as a lack of leadership continues to prevent research breakthroughs from reaching patients and sees the NHS miss clear opportunities to save lives. It assesses the most up-to-date UK
This guidance specifies the technique that should be used in screening women with breast implants. This is stated in the national service specification.
This document sets out the national standards for the NHS Breast Screening Programme which provide a defined set of measures that screening providers must meet to make sure local services are safe and effective. These revised programme standards have an